In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and released ShadowVIMP, an R...
On October 23, 2025, Staburo, represented by Tim Müller, attended the PSI/EFSPI Vaccines Statistics Workshop at the GSK site in Wavre. The workshop brought together a focused group of highly knowledgeable statisticians and researchers working in vaccines and...
Staburo GmbH was represented by our Managing Director, Roland Stieger, at the Biotechnology Innovation Organization (BIO) International Convention from June 16-19, 2025, in Boston. It was an exceptional opportunity to connect with full-service CROs, biotech and big...
From June 8th to 11th, 2025, Staburo was excited to participate in the highly anticipated PSI Annual Conference, held in Wembley, London. This event, considered one of the most important gatherings in the pharmaceutical and healthcare sectors, brought together a...
We were delighted to welcome two highly experienced trainers, Dr. Andreas Berk and Helge Bonaventura from InnovationTriologie, to our Munich office for an engaging hybrid training session on the updated ICH E6 (R3) guideline. The training offered a...
Inspired by the internal Estimand Strategic Initiatives Working Group and through many fruitful discussions with biostatisticians, disclosure managers, and medical writers, our Senior Disclosure Manager and Medical Writer, Ulrike Fischer has come to appreciate just...
From March 24 to March 28, 2025, the Staburo team had the pleasure of attending DAGStat 2025 in Berlin – one of the leading events for statisticians across academia, industry, and regulatory science.
We’re proud that Staburo was one of the sponsors of the conference. It was great to see our logo across the venue and to be part of such a vibrant community.
From March 2nd to 4th, Staburo colleagues Birte Clasen and Matthias Lehr attended the ACDM Annual Conference in Prague. With around 450 participants from over 180 organizations, the event brought together industry professionals for three days of knowledge-sharing,...
We’re happy to share that Staburo is supporting a Transdisciplinary Thesis Advisory Committee (TTAC) for a doctoral researcher at the Konrad Zuse School of Excellence in Reliable AI, based at TUM. The TTAC is tailored to each doctoral researcher,...
Wrapping up an exciting 2024 conference season and gearing up for an eventful 2025 for Staburo GmbH! Last November, we had the privilege of attending the Phuse EU Connect 2024 in beautiful Strasbourg, a flagship event for statistical programmers in...
Our Staburo colleagues Dr. Hannes Buchner (Managing Director) and Tim Müller (Data Scientist) have the honour of presenting at the Biometric Colloquium at the Medical University of Vienna in about two weeks’ time. Here are a few details and the abstract of the...
As we step into a new year, here’s a recap of key highlights from 2024 in the field of biomarkers at Staburo. June: At the PSI conference in Amsterdam, biomarkers were the focus of a dedicated session, followed by an in-person meeting of the PSI/EFSPI Biomarker...